GE HealthCare Technologies Inc. Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
9.5%projected annual EPS growth
Analyst Coverage
18analysts covering
FY Revenue (est.)
$21.7Bnext fiscal year
FY EPS (est.)
$4.93next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Next Earnings Release | 28 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Organic orders growth (%) Quarterly11.1%
Book-to-bill ratio Quarterly115.0%
Backlog (USD billions) Quarterly23.9
Adjusted EBIT margin (%) Quarterly14.2%Target: 15.4%-15.7% for full-year 2026
Organic revenue growth (%) Quarterly3.5%Target: 3.0%-4.0% for full-year 2026
Watch Items
- Demand conversion and backlog qualityAction: Review order conversion, cancellations, customer capital-spending conditions, and the expected timing of backlog realization.
- Inflation and adjusted-margin recoveryAction: Reassess the likelihood of achieving full-year adjusted EBIT margin guidance and test whether pricing and productivity are offsetting input-cost pressure.
- Patient Care Solutions turnaroundAction: Evaluate segment restructuring, strategic-option milestones, profitability trends, and potential effects on consolidated growth.
Research as of 29 Aug 2026